ArticleFrontiers in oncology2022

Pembrolizumab monotherapy for untreated PD-L1-Positive non-small cell lung cancer in the elderly or those with poor performance status: A prospective observational study.

Shinsuke Shiotsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.